Proposed carbohydrate antigen 19-9 (CA19-9) cut-off values for the detection of pancreatic cancer in patients with poorly controlled diabetes: a real-world study-Reference-Cited by-同舟云学术

Proposed carbohydrate antigen 19-9 (CA19-9) cut-off values for the detection of pancreatic cancer in patients with poorly controlled diabetes: a real-world study

Published:2023 Issue:11 Volume:70 Page:1069-1075
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Yamada Taku¹,Minami Taichi¹,Yamada Masayo²,Terauchi Yasuo³

Affiliation:

1. Department of Diabetes and Endocrinology, Saiseikai Yokohamashi Nanbu Hospital, Yokohama 234-0054, Japan

2. Department of Internal Medicine, Division of Metabolism and Endocrinology, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, Yokohama 247-0005, Japan

3. Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University, Yokohama 236-0004, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/70/11/70_EJ23-0186/_pdf

Reference31 articles.

1. 1 Ushio J, Kanno A, Ikeda E, Ando K, Nagai H, et al. (2021) Pancreatic ductal adenocarcinoma: epidemiology and risk factors. Diagnostics (Basel) 11: 562.

2. 2 Mizrahi DJ, Surana R, Valle JW, Shroff RT (2020) Pancreatic cancer. Lancet 395: 2008–2020.

3. 3 Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer: A meta-analysis. JAMA 273: 1605–1609.

4. 4 Andersen KD, Korc M, Petersen GM, Eibl G, Li D, et al. (2017) Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes 66: 1103–1110.

5. 5 Aggarwal G, Kamada P, Chari ST (2013) Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. Pancreas 42: 198–201.